指南与共识脊柱关节炎

2025年阿拉伯海湾国家中轴型脊柱关节炎转诊、诊断、监测和管理共识建议

2025 Consensus-based recommendations for the referral, diagnosis, monitoring, and management of axial spondyloarthritis in the Arabian Gulf countries.
指南 / 共识 · Semin Arthritis Rheum · 2025-09-09

该共识由巴林、科威特、阿曼、卡塔尔、沙特阿拉伯和阿联酋的七位风湿病专家组成的工作组制定,基于系统文献综述(PROSPERO CRD42023403697)并经≥70%同意度形成共识。最终产出6条总体原则和21条针对区域需求的建议,涵盖及时转诊、HLA-B27诊断价值、共享决策、多学科管理、影像学培训、骶髂关节MRI首选诊断、生物类似药优先、治疗失败再评估、心血管风险与妊娠监测及注册登记等。

要点

  • 共识形成6条总体原则和21条建议,共识同意度需≥70%。
  • 骶髂关节MRI为诊断首选,脊柱MRI或骶髂关节CT为替代方案。
  • 推荐优先使用生物类似药等成本效益好的治疗及替代给药途径。

核心结论

  • 这是首个针对阿拉伯海湾地区定制的axSpA共识建议,整合当前证据与区域 expertise 以优化患者管理。

研究设计与样本

  • 由巴林、科威特、阿曼、卡塔尔、沙特阿拉伯和阿联酋的七位风湿病专家及一名顾问组成工作组。
  • 基于PubMed、Medline和Cochrane数据库的系统文献综述(PROSPERO CRD42023403697)起草建议。
  • 共识要求同意度≥70%,并由该区域患者研究伙伴和风湿病专家进行外部验证。

主要发现

  • 制定了6条总体原则和21条针对区域需求的建议。
  • 关键原则涉及及时转诊至风湿病专家、HLA-B27的诊断效用、共享决策及结合非药物和药物治疗的多学科管理。
  • 推荐对风湿病专家和放射科医生进行影像学培训。
  • 骶髂关节MRI为诊断首选,脊柱MRI或骶髂关节CT为替代方案。
  • 推荐优先使用生物类似药等成本效益好的治疗及替代给药途径。

关键数值与推荐

  • 共识同意度阈值为≥70%。
  • 骶髂关节MRI为诊断首选,脊柱MRI或骶髂关节CT为替代方案。
  • 推荐优先使用生物类似药等成本效益好的治疗及替代给药途径。
  • 治疗失败应促使重新评估诊断并评估合并症。

临床怎么用

  • 及时转诊至风湿病专家并应用HLA-B27辅助诊断。
  • 诊断首选骶髂关节MRI,替代方案为脊柱MRI或骶髂关节CT。
  • 优先选择生物类似药等成本效益好的治疗及替代给药途径。
  • 治疗失败时重新评估诊断并排查合并症。
  • 定期监测心血管风险、妊娠规划及孕期疾病活动度,并使用电子患者报告结局指标辅助决策。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Standardized recommendations for managing axial spondyloarthritis (axSpA) in the context of the Arabian Gulf region are currently limited. OBJECTIVE: We aimed to develop evidence-based consensus recommendations for the referral, diagnosis, monitoring, and management of axSpA patients in the Arabian Gulf countries. METHOD: A task force of seven expert rheumatologists from Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates, along with an advisor, drafted recommendations regarding axSpA patient care based on a systematic literature review (PROSPERO CRD42023403697) of PubMed, Medline, and Cochrane databases. Consensus required a level of agreement ≥70%. Patient research partners and rheumatologists from the region externally validated the statements. RESULTS: Six overarching principles and 21 recommendations, tailored to the needs of the region, were developed. Key principles discussed timely referral to rheumatologists, the diagnostic utility of HLA-B27, shared decision-making, and multidisciplinary management combining non-pharmacological and pharmacological treatment. Training rheumatologists and radiologists on imaging is recommended. MRI of sacroiliac joints is preferred for diagnosis, with spinal MRI or CT of SIJs as alternatives. Cost-effective treatments, such as biosimilars, and alternative routes of drug administration should be prioritized. Treatment failure should prompt reassessment of diagnosis and evaluation of comorbidities. Regularly monitoring cardiovascular risk, pregnancy planning, disease activity monitoring during pregnancy, and use of electronic patient-reported outcome measures for informed decisions are recommended. Regional and national axSpA registries can facilitate evidence generation and enhance management. CONCLUSION: These are the first consensus recommendations tailored to the Arabian Gulf setting, integrating current evidence and regional expertise to optimize the care of axSpA patients.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Alnaqbi KA, Aldabie G, Enizi AA, et al. 2025 Consensus-based recommendations for the referral, diagnosis, monitoring, and management of axial spondyloarthritis in the Arabian Gulf countries. Semin Arthritis Rheum. 2025. PMID: 41045867. doi:10.1016/j.semarthrit.2025.152828

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。